top of page

InBody Oceania: How can InBody devices be utilised in Weight Loss Interventions and Treatment of Metabolic Syndrome?

What is Metabolic Syndrome?

Metabolic syndrome is a cluster of conditions that occur together and increase the risk of chronic diseases such as heart disease and type two diabetes. These conditions include high blood pressure, high blood glucose levels, excess abdominal fat, and abnormal cholesterol/triglyceride levels.

How is Metabolic Syndrome Treated?

Early detection and intervention is crucial to reduce the risk of chronic disease development in metabolic syndrome. Once a comprehensive assessment has identified the main components contributing to metabolic syndrome, lifestyle modifications and appropriate medical treatments are put into place. Treatments may include:

  • Nutrition therapy (E.g., calorie restriction, decreasing salt intake, increasing fibre intake)

  • Physical exercise 

  • Multi-disciplinary care (Physicians, Dietitians, Psychologists, Physiotherapists)

  • Medications to treat obesity

  • Bariatric surgery 

InBody offers health professionals results they can trust to tailor interventions aimed at preventing the progression of metabolic syndrome. Here are just a few examples of the parameters used to aid in weight loss management:

Body Fat Mass and Percentage Body Fat

Tracking changes in Body Fat Mass (kg) and Percentage Body Fat allows health professionals to quantify patient’s progress toward established weight loss goals.  



Visceral Fat Area

Whilst any excess fat mass can increase health risks, it is also important to consider the location of the fat within a person’s body. Research has shown that fat in the abdominal cavity is more strongly associated with components of metabolic syndrome (high blood pressure, elevated triglyceride levels) and development of chronic disease. InBody devices provide an estimate of fat located in the abdominal cavity with Visceral Fat Area.

 

Phase Angle

A marker of nutritional status in many clinical conditions – Phase Angle can also be used to monitor the progression of metabolic risk factors and efficacy of weight loss interventions. 

 

Skeletal Muscle Mass

It is of the utmost importance that excessive lean mass loss is prevented during weight loss interventions. Maintaining sufficient skeletal muscle mass is crucial for controlling blood glucose levels, as this tissue is the primary site for insulin-stimulated glucose utilisation. 


ECW/TBW Ratio 

Many scientific studies have found that obesity is associated with an ECW/TBW Ratio above the normal range. In obesity, a high ECW/TBW Ratio can be linked with impaired glucose tolerance, reduced lipolysis (triglyceride breakdown), and increased risk of diabetes. Weight loss interventions have shown effectiveness in decreasing ECW/TBW ratio and reducing the associated risks. 

We are pleased to announce that InBody will be exhibiting at the IFSO (International Federation for the Surgery of Obesity and Metabolic Disorders) World Conference in Melbourne on the 3rd-6th of September. We look forward to contributing to IFSO’s mission and assisting health professionals in the treatment of individuals with adiposity-based chronic disease.


07 5681 1900



Commentaires

bottom of page